Kansas City, Missouri — According to state and local economic development sources Viracor Eurofins Clinical Diagnostics plans to build out 100,000 square feet of new space in Kansas City. The company plans to occupy the new space in Kansas City, on or about October 1, 2022. According to the company website With over 30 years of specialized expertise in infectious disease, immunology, transplant, and allergy testing for immunocompromised and critical patients, Viracor Eurofins is committed to helping medical professionals, transplant teams, reference labs and biopharmaceutical companies get results faster, when it matters most. Viracor Eurofins is passionate about providing timely, actionable test results, never losing sight of the connection between the testing we perform and the patients our results ultimately serve.

To learn more about Viracor Eurofins Clinical Diagnostics, visit http://www.viracor-eurofins.com/

Company Contact:
Michelle Altrich, Chief Scientific Officer
michellealtrich@viracor-eurofins.com
https://www.linkedin.com/in/michelle-altrich-66304513/
800-305-5198

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved